Central Nervous System–Specific Outcomes of Phase...

Central Nervous System–Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma

Abstract

This cohort study determines the proportion of phase 3 clinical trials for patients with metastatic breast cancer, lung cancer, and melanoma that included patients with brain metastases and/or evaluated central nervous system–specific end points.

Authors

Corbett K; Sharma A; Pond GR; Brastianos PK; Das S; Sahgal A; Jerzak KJ

Journal

JAMA Oncology, Vol. 7, No. 7, pp. 1062–1064

Publisher

American Medical Association (AMA)

Publication Date

July 1, 2021

DOI

10.1001/jamaoncol.2021.1359

ISSN

2374-2437

Associated Experts

Gregory Pond

Professor, Faculty of Health Sciences

Visit profile

Labels